These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 26097044)
1. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients. Kaplan FS; Kobori JA; Orellana C; Calvo I; Rosello M; Martinez F; Lopez B; Xu M; Pignolo RJ; Shore EM; Groppe JC Am J Med Genet A; 2015 Oct; 167A(10):2265-71. PubMed ID: 26097044 [TBL] [Abstract][Full Text] [Related]
2. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Kaplan FS; Xu M; Seemann P; Connor JM; Glaser DL; Carroll L; Delai P; Fastnacht-Urban E; Forman SJ; Gillessen-Kaesbach G; Hoover-Fong J; Köster B; Pauli RM; Reardon W; Zaidi SA; Zasloff M; Morhart R; Mundlos S; Groppe J; Shore EM Hum Mutat; 2009 Mar; 30(3):379-90. PubMed ID: 19085907 [TBL] [Abstract][Full Text] [Related]
3. A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene. Cappato S; Traberg R; Gintautiene J; Zara F; Bocciardi R Mol Genet Genomic Med; 2021 Oct; 9(10):e1774. PubMed ID: 34347384 [TBL] [Abstract][Full Text] [Related]
4. Nonclassic fibrodysplasia ossificans progressiva: A child from Angola with an ACVR1 Martín-García D; Towler OW; Xu M; Alfonso-Hernández O; Oliveira PR; Alonso-Clavo M; Shore EM; Kaplan FS Am J Med Genet A; 2021 Aug; 185(8):2572-2575. PubMed ID: 33973349 [TBL] [Abstract][Full Text] [Related]
5. An ACVR1 Kaplan FS; Groppe JC; Xu M; Towler OW; Grunvald E; Kalunian K; Kallish S; Al Mukaddam M; Pignolo RJ; Shore EM Am J Med Genet A; 2022 Mar; 188(3):806-817. PubMed ID: 34854557 [TBL] [Abstract][Full Text] [Related]
6. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling. Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160 [TBL] [Abstract][Full Text] [Related]
7. Reduced GS Domain Serine/Threonine Requirements of Fibrodysplasia Ossificans Progressiva Mutant Type I BMP Receptor ACVR1 in the Zebrafish. Allen RS; Jones WD; Hale M; Warder BN; Shore EM; Mullins MC J Bone Miner Res; 2023 Sep; 38(9):1364-1385. PubMed ID: 37329499 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Bocciardi R; Bordo D; Di Duca M; Di Rocco M; Ravazzolo R Eur J Hum Genet; 2009 Mar; 17(3):311-8. PubMed ID: 18830232 [TBL] [Abstract][Full Text] [Related]
9. Variable signaling activity by FOP ACVR1 mutations. Haupt J; Xu M; Shore EM Bone; 2018 Apr; 109():232-240. PubMed ID: 29097342 [TBL] [Abstract][Full Text] [Related]
10. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation. van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification. Yamamoto M; Stoessel SJ; Yamamoto S; Goldhamer DJ J Bone Miner Res; 2022 Nov; 37(11):2077-2093. PubMed ID: 35637634 [TBL] [Abstract][Full Text] [Related]
13. Depletion of Mast Cells and Macrophages Impairs Heterotopic Ossification in an Acvr1 Convente MR; Chakkalakal SA; Yang E; Caron RJ; Zhang D; Kambayashi T; Kaplan FS; Shore EM J Bone Miner Res; 2018 Feb; 33(2):269-282. PubMed ID: 28986986 [TBL] [Abstract][Full Text] [Related]
14. ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report. Nakahara Y; Katagiri T; Ogata N; Haga N Am J Med Genet A; 2014 Jan; 164A(1):220-4. PubMed ID: 24259422 [TBL] [Abstract][Full Text] [Related]
15. ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant. Haupt J; Deichsel A; Stange K; Ast C; Bocciardi R; Ravazzolo R; Di Rocco M; Ferrari P; Landi A; Kaplan FS; Shore EM; Reissner C; Seemann P Hum Mol Genet; 2014 Oct; 23(20):5364-77. PubMed ID: 24852373 [TBL] [Abstract][Full Text] [Related]
16. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call. Towler OW; Shore EM; Xu M; Bamford A; Anderson I; Pignolo RJ; Kaplan FS Eur J Med Genet; 2017 Jul; 60(7):399-402. PubMed ID: 28473268 [TBL] [Abstract][Full Text] [Related]
17. Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1 Wentworth KL; Lalonde RL; Groppe JC; Brewer N; Moody T; Hansberry S; Taylor KE; Shore EM; Kaplan FS; Pignolo RJ; Yelick PC; Hsiao EC J Bone Miner Res; 2022 Nov; 37(11):2058-2076. PubMed ID: 36153796 [TBL] [Abstract][Full Text] [Related]
19. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Hino K; Ikeya M; Horigome K; Matsumoto Y; Ebise H; Nishio M; Sekiguchi K; Shibata M; Nagata S; Matsuda S; Toguchida J Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15438-43. PubMed ID: 26621707 [TBL] [Abstract][Full Text] [Related]
20. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]